Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Thomas Samuel, MD

877.463.2010

Thomas Samuel, MD

Appointed: 2013

Thomas Samuel, MD
Department: Hematology and Oncology
Associate Staff
Location: Florida, Weston
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:877.463.2010
WorkFax:954.659.5810
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr. Thomas Samuel specializes in all aspects of breast cancer care including breast cancer risk assessment, breast cancer chemoprevention, adjuvant chemotherapy and endocrine therapy for breast cancer, and advanced breast cancer care including palliation. Prior to joining the Cleveland Clinic Florida, Dr. Samuel was Associate Professor of Medicine at the Georgia Regents University-Medical College of Georgia Cancer Center working as the Director of the GRU Multidisciplinary Breast Cancer Program which he founded it in 2006. Dr. Samuel was previously Assistant Professor of Medicine at Fox Chase Cancer Center with a joint appointment at the Temple University School of Medicine in Philadelphia,Pennsylvania. At Fox Chase, Dr.Samuel worked with the nationally renowned Fox Chase Pain Management and Palliative Care Center,where he specialized in cancer-related pain issues and hospice care.

He is currently a member of the multidisciplinary team in breast oncology at Cleveland Clinic Florida as well as active in developing and implementing all phases of clinical and translational research. Dr.Samuel completed his undergraduate training at Swarthmore College and obtained his medical degree from the State University of New York (SUNY) at Stony Brook. He finished a residency in internal medicine at Vanderbilt University Medical Center in Nashville, followed by a specialty fellowship in hematology/oncology at Fox Chase Cancer Center and Temple University School of Medicine. Board certified in internal medicine and medical oncology, his particular interests are in breast cancer treatment with a focus on early development of novel therapeutics, supportive oncology, and palliative care. As a son of a breast cancer survivor, he finds it his unique privilege to take care of patients afflicted with breast cancer at all stages.

Education & Fellowships

Fellowship - Temple University Hospital
Hematology/Medical Oncology
Philadelphia, PA USA
2004
Residency - Vanderbilt University Medical Center
Internal Medicine
Nashville, TN USA
2001
Medical School - State University of New York at Stony Brook
Stony Brook, NY USA
1998
Undergraduate - Swarthmore College
Biochemistry
Swarthmore, PA USA
1994

Certifications

  • Internal Medicine- Medical Oncology

Specialty Interests

Breast Cancer, Palliative Care, Medical Education, Clinical Research

Awards & Honors

  • Swarthmore College: Kennedy Scholarship (1990-94)
  • National Science Foundation Scholarship for Minority Development (1991)
  • State University of New York at Stony Brook School of Medicine:1998 SUNY at Stony Brook School of Medicine Convocation Student Speaker (05/1998-elected by student body)
  • Vanderbilt University Medical Center, School of Medicine: Medical Student Curriculum Committee Resident Teaching Award (07/2001)
  • Medical College of Georgia, School of Medicine: Outstanding Young Clinical Sciences Faculty Senate Award (04/2009)
  • Medical College of Georgia, School of Medicine Exemplary Teaching Award for Resident Education (04/2009)
  • Keynote Speaker at 2011 Inaugural Gold Humanism Society Induction Ceremony (03/2011)
  • Alpha Omega Alpha (AOA) Honor Medical Society Induction-(04/2013)

Memberships

  • American College of Physicians (1995-present)
  • American Medical Association(1996-present)
  • American Society of Clinical Oncology (ASCO) (2001-present)

Treatment & Services

  • Breast Cancer Risk Assessment
  • Breast Exam
  • Breast Health
  • Cancer Anorexia And Weight Loss
  • Cancer Risk Assessment
  • Cancer Screening
  • Cancer Supportive Care
  • Chemoprevention
  • Chemotherapy
  • Endocrine Treatment
  • Inpatient Care
  • Palliative Medicine

Specialty in Diseases and Conditions

  • Breast Cancer
  • Cancer Complications
  • Cancer Fatigue
  • Cancer Pain
  • Cancer Symptoms
  • Genetics, Cancer

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/28/2014, Dr. Samuel has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Malayalam